Israel - heprea - Ministry of Health

ben shimon floris ltd, israel - zinc as oxide - תרחיץ - zinc as oxide 20 % - zinc bandage without supplements

Israel - heprea - Ministry of Health

ben shimon floris ltd, israel - hydrogen peroxide - תמיסה - hydrogen peroxide 3 %w/w - hydrogen peroxide

Israel - heprea - Ministry of Health

ben shimon floris ltd, israel - chlorhexidine digluconate - תמיסה (פומי) - chlorhexidine digluconate 0.2 %w/v - chlorhexidine

Israel - heprea - Ministry of Health

ben shimon floris ltd, israel - chlorhexidine digluconate; isopropanol - תמיסה - isopropanol 70 %v/v; chlorhexidine digluconate 0.5 %w/v - chlorhexidine

Israel - heprea - Ministry of Health

ben shimon floris ltd, israel - chlorhexidine digluconate; isopropanol - תמיסה - isopropanol 70 %v/v; chlorhexidine digluconate 2 %w/v - chlorhexidine

Israel - heprea - Ministry of Health

ben shimon floris ltd, israel - chlorhexidine gluconate - תמיסה - chlorhexidine gluconate 0.2 %w/v - chlorhexidine

Israel - heprea - Ministry of Health

ben shimon floris ltd, israel - chlorhexidine digluconate - ג'ל - chlorhexidine digluconate 1 %w/w - chlorhexidine

Israel - heprea - Ministry of Health

merck serono ltd - bisoprolol fumarate - טבליה - bisoprolol fumarate 10 mg - bisoprolol - bisoprolol - hypertension. coronary heart disease (angina pectoris).

Israel - heprea - Ministry of Health

merck serono ltd - follitropin alfa - תמיסה להזרקה - follitropin alfa 600 iu/ml - follitropin alfa - follitropin alfa - gonal-f followed by chorionic gonadotrophin (hcg), is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf), gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermat

Israel - heprea - Ministry of Health

merck serono ltd - cetrorelix as acetate - אבקה וממס להכנת תמיסה להזרקה - cetrorelix as acetate 0.25 mg/vial - cetrorelix - cetrorelix - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.